サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1178084

脂質ベース製剤の世界市場：脂質源別、用途別、流通チャネル別、地域別、業界規模、シェア、動向、競合、機会、予測（2017年～2027年）

Lipid Based Formulations Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Source of Lipids, By Application, By Distribution Channel, By Region
出版日: | 発行: TechSci Research | ページ情報: 英文 113 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

脂質ベース製剤の世界市場：脂質源別、用途別、流通チャネル別、地域別、業界規模、シェア、動向、競合、機会、予測（2017年～2027年）
出版日: 2022年12月01日
発行: TechSci Research
ページ情報: 英文 113 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の脂質ベース製剤の市場規模は、予測期間（2023年～2027年）中に目覚しいCAGRで成長すると予測されています。

先端医療に対する需要の急増と経口投与薬の需要の増加、慢性疾患・感染症・伝染病の増加は、市場の成長を促進しています。

当レポートでは、世界の脂質ベース製剤市場について調査分析し、製品概要、市場の展望、競合情勢など、体系的な情報を提供しています。

目次

第1章 製品概要

第2章 調査手法

第3章 世界の脂質ベース製剤市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 VOC (顧客の声)

  • 選好：脂質源別
  • 脂質ベース製剤の需要に寄与する要因
  • 脂質ベースの処方の採用に対する障壁
  • ブランド認知度

第6章 臨床試験

  • 進行中の臨床試験
  • 完了した臨床試験
  • 中断した臨床試験
  • 臨床試験分析

第7章 特許分析

  • 特許取得済み（2017年～2021年）
  • 特許出願

第8章 市販の脂質ベース製剤のリスト

第9章 世界の脂質ベース製剤市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 脂質源別（天然化学合成）
    • 用途別（真菌性疾患、腫瘍学、遺伝子治療、抗ウイルスワクチン、その他）
    • 流通チャネル別（小売薬局、病院薬局、オンライン薬局）
    • 企業別（2021年）
    • 地域別
  • 製品市場マップ

第10章 北米の脂質ベース製剤市場の展望

第11章 欧州の脂質ベース製剤市場の展望

第12章 アジア太平洋の脂質ベース製剤市場の展望

第13章 南米の脂質ベース製剤市場の展望

第14章 中東およびアフリカの脂質ベース製剤市場の展望

第15章 市場力学

  • 促進要因
  • 課題

第16章 市場の動向と開発

第17章 競合情勢

  • Novartis AG
  • AbbVie, Inc.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Alnylam Pharmaceuticals Inc.

第18章 戦略的提言

目次
Product Code: 8209

Global lipid based formulations market is anticipated to grow with an impressive CAGR in the forecast period, 2023-2027, on account of growing pharmaceutical industry. Rapidly surging demands for the advanced medicine and growing demand for oral administrated medicine is driving the growth of the global lipid formulations market in the upcoming five years.

Lipid based formulations are bio-chemical compounds that are artificially synthesized to facilitate the drug administration, while ensuring safety of the drug along with bio-solubility of it for the digestion and faster action of the main drug component inside the formulation. Lipid based formulations aid the primary mechanism of action for the drug that leads to bioavailability. In simpler terms, highly water soluble drugs if gets dissolved in the starting of gut, may not reach the target site, or target organ and thus its efficiency decreases. To alter this effect, a lipid based formulation is utilized. Lipids form a hydrophobic bonds around the drug and avoid dissolution partially or completely until it reaches the target site. With digestion of the lipid bonds by the process of triglyceride digestion, the drug gets delivered in the later parts of gastrointestinal tract.

Pharmaceutical Advancements Drive Market Growth

Consistent research and development of the drugs such that they have higher bio-availability, higher effect on the target site, to improve facilitation of the drug to create its effect at the target site, is driving the growth of the global lipid based formulations market in the upcoming five years. A major concern among the drug delivery system is that, for the oral administration of the drug, it has tendency to get dissolved or digested before reaching the target site. In such cases, the drug if get dissolved would leave the gastrointestinal tract without being absorbed in the blood. To avoid this untimely dissolution, lipid based formulations are utilized to enhance the drug durability and absorption thus substantially increasing its affinity as a treatment for a particular diseases.

Growing Investments In Healthcare Industry Supports Market

Governments from major economies are actively investing in their respective healthcare sectors to enhance the services and products such that best possible patient care can be provided. Increasing instances of chronic, infectious, and communicable diseases, is further anticipated to drive the growth of the global lipid based formulations market in the upcoming five years. Consistent research and technological advancement for the pharmaceutical product development and advancement of the drug delivery systems, is also anticipated to substantiate the growth of the global lipid based formulations market in the future five years.

Market Segmentation

The global lipid based formulations market segmentation is based on source of lipids, application, distribution channel, regional distribution, and competitive landscape. Based on source of lipids, the market is differentiated between natural and chemically synthesized sources. Application based segments of the market is distinguished among fungal diseases, oncology, gene therapy, antiviral vaccines, and others. Based on distribution channel, the market is fragmented into retail pharmacies, hospital pharmacies, and online pharmacies. The market analysis also studies the regional segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Company Profile

Novartis AG, AbbVie, Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Alnylam Pharmaceuticals Inc., are enlisted in a partial list of major market players of the global lipid based formulations market.

Report Scope:

In this report, global lipid based formulations market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Lipid Based Formulations Market, By Source of Lipids:

Natural

Chemically Synthesized

  • Lipid Based Formulations Market, By Application:

Fungal Diseases

Oncology

Gene Therapy

Antiviral Vaccines

Others

  • Lipid Based Formulations Market, By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

  • Lipid Based Formulations Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global lipid based formulations market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Lipid Based Formulations Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Preference, By Source of Lipids
  • 5.2. Factors Contributing to Demand for Lipid Based Formulations
  • 5.3. Barriers to Adoption of Lipid Based Formulations
  • 5.4. Brand Awareness

6. Clinical Trials

  • 6.1. Ongoing Clinical Trials
  • 6.2. Completed Clinical Trials
  • 6.3. Terminated Clinical Trials
  • 6.4. Clinical Trial Analysis

7. Patent Analysis

  • 7.1. Patent Granted (2017-2021)
  • 7.2. Patent Applications Filed

8. List of Commercially Available Lipid Based Formulations

9. Global Lipid Based Formulations Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source of Lipids (Natural v/s Chemically Synthesized)
    • 9.2.2. By Application (Fungal Diseases, Oncology, Gene Therapy, Antiviral Vaccines, Others)
    • 9.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
    • 9.2.4. By Company (2021)
    • 9.2.5. By Region
  • 9.3. Product Market Map

10. North America Lipid Based Formulations Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source of Lipids
    • 10.2.2. By Application
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. North America: Country Analysis
    • 10.3.1. United States Lipid Based Formulations Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Source of Lipids
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Mexico Lipid Based Formulations Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Source of Lipids
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Canada Lipid Based Formulations Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Source of Lipids
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Distribution Channel

11. Europe Lipid Based Formulations Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Source of Lipids
    • 11.2.2. By Application
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country
  • 11.3. Europe: Country Analysis
    • 11.3.1. France Lipid Based Formulations Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Source of Lipids
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By Distribution Channel
    • 11.3.2. Germany Lipid Based Formulations Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Source of Lipids
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By Distribution Channel
    • 11.3.3. United Kingdom Lipid Based Formulations Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Source of Lipids
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By Distribution Channel
    • 11.3.4. Italy Lipid Based Formulations Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Source of Lipids
        • 11.3.4.2.2. By Application
        • 11.3.4.2.3. By Distribution Channel
    • 11.3.5. Spain Lipid Based Formulations Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Source of Lipids
        • 11.3.5.2.2. By Application
        • 11.3.5.2.3. By Distribution Channel

12. Asia-Pacific Lipid Based Formulations Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Source of Lipids
    • 12.2.2. By Application
    • 12.2.3. By Distribution Channel
    • 12.2.4. By Country
  • 12.3. Asia-Pacific: Country Analysis
    • 12.3.1. China Lipid Based Formulations Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Source of Lipids
        • 12.3.1.2.2. By Application
        • 12.3.1.2.3. By Distribution Channel
    • 12.3.2. India Lipid Based Formulations Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Source of Lipids
        • 12.3.2.2.2. By Application
        • 12.3.2.2.3. By Distribution Channel
    • 12.3.3. South Korea Lipid Based Formulations Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Source of Lipids
        • 12.3.3.2.2. By Application
        • 12.3.3.2.3. By Distribution Channel
    • 12.3.4. Japan Lipid Based Formulations Market Outlook
      • 12.3.4.1. Market Size & Forecast
        • 12.3.4.1.1. By Value
      • 12.3.4.2. Market Share & Forecast
        • 12.3.4.2.1. By Source of Lipids
        • 12.3.4.2.2. By Application
        • 12.3.4.2.3. By Distribution Channel
    • 12.3.5. Australia Lipid Based Formulations Market Outlook
      • 12.3.5.1. Market Size & Forecast
        • 12.3.5.1.1. By Value
      • 12.3.5.2. Market Share & Forecast
        • 12.3.5.2.1. By Source of Lipids
        • 12.3.5.2.2. By Application
        • 12.3.5.2.3. By Distribution Channel

13. South America Lipid Based Formulations Market Outlook

  • 13.1. Market Size & Forecast
    • 13.1.1. By Value
  • 13.2. Market Share & Forecast
    • 13.2.1. By Source of Lipids
    • 13.2.2. By Application
    • 13.2.3. By Distribution Channel
    • 13.2.4. By Country
  • 13.3. South America: Country Analysis
    • 13.3.1. Brazil Lipid Based Formulations Market Outlook
      • 13.3.1.1. Market Size & Forecast
        • 13.3.1.1.1. By Value
      • 13.3.1.2. Market Share & Forecast
        • 13.3.1.2.1. By Source of Lipids
        • 13.3.1.2.2. By Application
        • 13.3.1.2.3. By Distribution Channel
    • 13.3.2. Argentina Lipid Based Formulations Market Outlook
      • 13.3.2.1. Market Size & Forecast
        • 13.3.2.1.1. By Value
      • 13.3.2.2. Market Share & Forecast
        • 13.3.2.2.1. By Source of Lipids
        • 13.3.2.2.2. By Application
        • 13.3.2.2.3. By Distribution Channel
    • 13.3.3. Colombia Lipid Based Formulations Market Outlook
      • 13.3.3.1. Market Size & Forecast
        • 13.3.3.1.1. By Value
      • 13.3.3.2. Market Share & Forecast
        • 13.3.3.2.1. By Source of Lipids
        • 13.3.3.2.2. By Application
        • 13.3.3.2.3. By Distribution Channel

14. Middle East and Africa Lipid Based Formulations Market Outlook

  • 14.1. Market Size & Forecast
    • 14.1.1. By Value
  • 14.2. Market Share & Forecast
    • 14.2.1. By Source of Lipids
    • 14.2.2. By Application
    • 14.2.3. By Distribution Channel
    • 14.2.4. By Country
  • 14.3. MEA: Country Analysis
    • 14.3.1. South Africa Lipid Based Formulations Market Outlook
      • 14.3.1.1. Market Size & Forecast
        • 14.3.1.1.1. By Value
      • 14.3.1.2. Market Share & Forecast
        • 14.3.1.2.1. By Source of Lipids
        • 14.3.1.2.2. By Application
        • 14.3.1.2.3. By Distribution Channel
    • 14.3.2. Saudi Arabia Lipid Based Formulations Market Outlook
      • 14.3.2.1. Market Size & Forecast
        • 14.3.2.1.1. By Value
      • 14.3.2.2. Market Share & Forecast
        • 14.3.2.2.1. By Source of Lipids
        • 14.3.2.2.2. By Application
        • 14.3.2.2.3. By Distribution Channel
    • 14.3.3. UAE Lipid Based Formulations Market Outlook
      • 14.3.3.1. Market Size & Forecast
        • 14.3.3.1.1. By Value
      • 14.3.3.2. Market Share & Forecast
        • 14.3.3.2.1. By Source of Lipids
        • 14.3.3.2.2. By Application
        • 14.3.3.2.3. By Distribution Channel

15. Market Dynamics

  • 15.1. Drivers
  • 15.2. Challenges

16. Market Trends & Developments

17. Competitive Landscape

  • 17.1. Novartis AG
  • 17.2. AbbVie, Inc.
  • 17.3. F. Hoffmann-La Roche AG
  • 17.4. Johnson & Johnson
  • 17.5. Alnylam Pharmaceuticals Inc.

18. Strategic Recommendations